Cargando…
Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
The aim of the present study was to identify novel antibody markers for the early diagnosis of atherosclerosis in order to improve the prognosis of patients at risk for acute ischemic stroke (AIS) and acute myocardial infarction (AMI). A first screening involved the serological identification of ant...
Autores principales: | Li, Shu-Yang, Yoshida, Yoichi, Kobayashi, Eiichi, Adachi, Akihiko, Hirono, Seiichiro, Matsutani, Tomoo, Mine, Seiichiro, Machida, Toshio, Ohno, Mikiko, Nishi, Eiichiro, Maezawa, Yoshiro, Takemoto, Minoru, Yokote, Koutaro, Kitamura, Kenichiro, Sumazaki, Makoto, Ito, Masaaki, Shimada, Hideaki, Takizawa, Hirotaka, Kashiwado, Koichi, Tomiyoshi, Go, Shinmen, Natsuko, Nakamura, Rika, Kuroda, Hideyuki, Zhang, Xiao-Meng, Wang, Hao, Goto, Kenichiro, Iwadate, Yasuo, Hiwasa, Takaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447314/ https://www.ncbi.nlm.nih.gov/pubmed/32945427 http://dx.doi.org/10.3892/ijmm.2020.4690 |
Ejemplares similares
-
Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
por: Yoshida, Yoichi, et al.
Publicado: (2020) -
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021) -
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack
por: Yoshida, Yoichi, et al.
Publicado: (2017) -
Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
por: Sumazaki, Makoto, et al.
Publicado: (2020) -
GADD34 activates p53 and may have utility as a marker of atherosclerosis
por: Tomiyoshi, Go, et al.
Publicado: (2023)